| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 National Institute for Biological Standards and Control, Holly Hill, Hampstead, London NW3 6RB, U.K.
2 Department of Microbiology, University of Reading, London Road, Reading RG1 5AQ, U.K.
and3 Research Institute of Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, California 92037, U.S.A.
The antigenic sites recognized by monoclonal antibodies with neutralizing activity for the Sabin vaccine strains of poliovirus of serotypes 1, 2 and 3 have been studied by the isolation and characterization of mutants resistant to neutralization by antibody. Three distinct sites have been identified which are designated site 1, site 2 and site 3. Site 1 includes a region of 12 amino acids of VP1, from residues 89 to 100, and a corresponding region of VP1 has been identified as an antigenic site for poliovirus 2. This site was strongly immunodominant in type 2 and type 3 but was not detected for poliovirus 1. Site 2 is a complex site including residues 220 to 222 from VP1 (site 2a) with residues including 169 and 170 and others of VP2 (site 2b). Both site 2a and site 2b have been detected in type 1 poliovirus, while as yet only site 2b has been detected in type 3 poliovirus. Site 3 is a complex site including residues 286 to 290 from VP1 (site 3a) with residues including 58 and 59 and others of VP3 (site 3b). Both sites 3a and 3b have been detected in type 3 poliovirus, while as yet only site 3b has been detected in type 1 poliovirus.
Keywords: poliovirus, neutralization epitopes, monoclonal antibodies
Received 29 January 1986;
accepted 7 April 1986.
This article has been cited by other articles:
|
|
 |
|
  S. Khan, X. Peng, J. Yin, P. Zhang, and E. Wimmer Characterization of the New World Monkey Homologues of Human Poliovirus Receptor CD155 J. Virol., July 15, 2008; 82(14): 7167 - 7179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Dedepsidis, Z. Kyriakopoulou, V. Pliaka, C. Kottaridi, E. Bolanaki, S. Levidiotou-Stefanou, D. Komiotis, and P. Markoulatos Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece Appl. Envir. Microbiol., November 1, 2007; 73(21): 6697 - 6704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-K. Lee, K. Kono, E. Haas, K.-S. Kim, K. M. Drescher, N. M. Chapman, and S. Tracy Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate J. Gen. Virol., January 1, 2005; 86(1): 197 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blomqvist, C. Savolainen, P. Laine, P. Hirttio, E. Lamminsalo, E. Penttila, S. Joks, M. Roivainen, and T. Hovi Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia J. Virol., May 1, 2004; 78(9): 4876 - 4883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alho, J. Marttila, J. Ilonen, and T. Hyypia Diagnostic Potential of Parechovirus Capsid Proteins J. Clin. Microbiol., June 1, 2003; 41(6): 2294 - 2299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Fry, N. J. Knowles, J. W. I. Newman, G. Wilsden, Z. Rao, A. M. Q. King, and D. I. Stuart Crystal Structure of Swine Vesicular Disease Virus and Implications for Host Adaptation J. Virol., May 1, 2003; 77(9): 5475 - 5486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blomqvist, A.-L. Bruu, M. Stenvik, and T. Hovi Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1 J. Gen. Virol., March 1, 2003; 84(3): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sanchez, R. M. Pinto, H. Vanaclocha, and A. Bosch Molecular Characterization of Hepatitis A Virus Isolates from a Transcontinental Shellfish-Borne Outbreak J. Clin. Microbiol., November 1, 2002; 40(11): 4148 - 4155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Wahby Combined Cell Culture Enzyme-Linked Immunosorbent Assay for Quantification of Poliovirus Neutralization- Relevant Antibodies Clin. Vaccine Immunol., November 1, 2000; 7(6): 915 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Verlinden, A. Cuconati, E. Wimmer, and B. Rombaut Cell-free synthesis of poliovirus: 14S subunits are the key intermediates in the encapsidation of poliovirus RNA J. Gen. Virol., November 1, 2000; 81(11): 2751 - 2754. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. J. Rebel, C. H. Leendertse, A. Dekker, F. van Poelwijk, and R. J. M. Moormann Construction of a full-length infectious cDNA clone of swine vesicular disease virus strain NET/1/92 and analysis of new antigenic variants derived from it J. Gen. Virol., November 1, 2000; 81(11): 2763 - 2769. [Abstract] [Full Text]
|
|
|
|
|
|
P. Joki-Korpela, M. Roivainen, H. Lankinen, T. Pöyry, and T. Hyypiä Antigenic properties of human parechovirus 1 J. Gen. Virol., July 1, 2000; 81(7): 1709 - 1718. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Dunn, N. M. Chapman, S. Tracy, and J. R. Romero Genomic Determinants of Cardiovirulence in Coxsackievirus B3 Clinical Isolates: Localization to the 5' Nontranslated Region J. Virol., May 15, 2000; 74(10): 4787 - 4794. [Abstract] [Full Text]
|
|
|
|
|
|
T. Herremans, J. H. J. Reimerink, T. G. Kimman, H. G. A. M. van der Avoort, and M. P. G. Koopmans Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure Clin. Vaccine Immunol., January 1, 2000; 7(1): 40 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Duncan and F. Colbère- Garapin Two determinants in the capsid of a persistent type 3 poliovirus exert different effects on mutant virus uncoating J. Gen. Virol., October 1, 1999; 80(10): 2601 - 2605. [Abstract] [Full Text]
|
|
|
|
|
|
J. H. J. Reimerink, H. G. A. M. van der Avoort, A. M. van Loon, and M. P. G. Koopmans Genetic Basis for Immunological Aberrations in Poliovirus Sabin Serotype 3 Strains Imported in The Netherlands J. Clin. Microbiol., August 1, 1999; 37(8): 2393 - 2398. [Abstract] [Full Text]
|
|
|
|
|
|
P. Muir, A. Ras, P. E. Klapper, G. M. Cleator, K. Korn, C. Aepinus, A. Fomsgaard, P. Palmer, A. Samuelsson, A. Tenorio, et al. Multicenter Quality Assessment of PCR Methods for Detection of Enteroviruses J. Clin. Microbiol., May 1, 1999; 37(5): 1409 - 1414. [Abstract] [Full Text]
|
|
|
|
|
|
M. Mulders, J. Reimerink, M Stenvik, I Alaeddinoglu, H. van der Avoort, T Hovi, and M. Koopmans A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1 J. Gen. Virol., April 1, 1999; 80(4): 907 - 916. [Abstract]
|
|
|
|
|
|
S. Nijhar, D. Mackay, E Brocchi, N. Ferris, R. Kitching, and N. Knowles Identification of neutralizing epitopes on a European strain of swine vesicular disease virus J. Gen. Virol., February 1, 1999; 80(2): 277 - 282. [Abstract]
|
|
|
|
 |
|
 P. Muir, U. Kammerer, K. Korn, M. N. Mulders, T. Poyry, B. Weissbrich, R. Kandolf, G. M. Cleator, and A. M. van Loon Molecular Typing of Enteroviruses: Current Status and Future Requirements Clin. Microbiol. Rev., January 1, 1998; 11(1): 202 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Murray, J Bradley, X. Yang, E Wimmer, E. Moss, and V. Racaniello Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I Science, July 8, 1988; 241(4862): 213 - 215. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
